Details of the SBP
General Information of Synthetic Binding Protein (SBP) (ID: SBP001013) | ||||||
---|---|---|---|---|---|---|
SBP Name |
Diabody anti-VEGF x anti-PD-1
|
|||||
Synonyms |
Anti-VEGF x anti-PD-1 diabody
|
|||||
Molecular Weight | 51 kDa | |||||
Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
Expression System | Pichia pastoris GS115 | |||||
Highest Status | Research | |||||
Template Name | Human VEGF165 mAb and Nivolumab | |||||
Protein Scaffold Information of This SBP | ||||||
---|---|---|---|---|---|---|
Scaffold ID | PS031 | [1] , [2] | ||||
Scaffold Name | Diabody | |||||
Scaffold Class | Antibody fragment | |||||
Fold Type | Beta-Sheets + Loops | |||||
Binding Target(s) of This SBP (BTS) |
---|
BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
---|---|---|---|---|---|---|
Vascular endothelial growth factor 165 | Inhibitor | Tumors [ICD-11: XH1N44] | Kd: 124.9 nM | China Pharmaceutical University | [1] , [2] | |
Programmed cell death protein 1 | Inhibitor | Tumors [ICD-11: XH1N44] | Kd: 25.1 nM | China Pharmaceutical University | [1] , [2] | |
References |
---|